Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.49 |
| ▸ | PKM | P14618 | 2/20 | 0.49 |
| ▸ | ALPG | P10696 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | GLS | O94925 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8092787 | 0.81 | POLB (0.42) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL47294 | 0.79 | POLB (0.50) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL3270695 | 0.79 | TSHR (0.51) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL21941834 | 0.79 | TSHR (0.51) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL8203284 | 0.78 | EGLN1 (0.38) | POLBHPGDALDH1A1TDP1 | |
| SCHEMBL24177181 | 0.76 | POLB (0.55) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL1472587 | 0.76 | POLB (0.55) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL6360835 | 0.76 | POLB (0.55) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL5963073 | 0.76 | POLB (0.48) | POLBPKMALPGHPGDALDH1A1 | |
| SCHEMBL9484968 | 0.76 | HPGD (0.49) | POLBPKMALPGHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2094246-B1 | SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME | TAKEDA PHARMACEUTICALS CO (JP) | 2020-04-01 | — | — | EP | disclosed |
| US-9713595-B2 | Sustained-release composition and method for producing the same | TAKEDA PHARMACEUTICALS COMPANY LIMITED (JP) | 2017-07-25 | — | — | US | disclosed |
| US-20170165204-A1 | SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-06-15 | — | — | US | disclosed |
| US-9617303-B2 | Sustained-release composition and method for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2017-04-11 | — | — | US | disclosed |
| EP-1466596-B1 | MICROSPHERE AND METHOD FOR PRODUCTION THEREOF | TAKEDA PHARMACEUTICAL (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-20150080322-A1 | SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8927016-B2 | Producing a sustained-release preparation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-01-06 | — | — | US | disclosed |
| US-8921326-B2 | Sustained-release composition and method for producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8815801-B2 | Controlled release composition and method of producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-08-26 | — | — | US | disclosed |
| US-20120295848-A1 | SUSTAINED-RELEASE COMPOSITION AND PROCESS FOR PRODUCING THE SAME | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2012-11-22 | — | — | US | disclosed |
| US-20040077531-A1 | Use of galanin-like peptide | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-04-22 | — | — | US | disclosed |
| EP-1360964-A1 | USE OF GALANIN-LIKE PEPTIDE | Takeda Chemical Industries, Ltd. (JP) | 2003-11-12 | — | — | EP | disclosed |
| EP-1330293-A2 | CONTROLLED RELEASE COMPOSITION COMPRISING LACTIC ACID POLYMER AND HYDROXYNAPHTHOIC ACID, AND METHOD OF PRODUCING THE SAME | Takeda Chemical Industries, Ltd. (JP) | 2003-07-30 | — | — | EP | disclosed |
| US-20030134800-A1 | Controlled release composition and method of producing the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2003-07-17 | — | — | US | disclosed |
| EP-1049458-B1 | LYOPHILIZATION METHOD FOR SUSTAINED-RELEASE PREPARATIONS | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-03-26 | — | — | EP | disclosed |
| WO-2003002092-A2 | CONTROLLED RELEASE COMPOSITION COMPRISING LACTIC ACID POLYMER AND HYDROXYNAPHTHOIC ACID, AND METHOD OF PRODUCING THE SAME | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2003-01-09 | — | — | WO | disclosed |
| EP-1197208-A1 | SUSTAINED RELEASE COMPOSITIONS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-04-17 | — | — | EP | disclosed |
| EP-1158014-A1 | PROCESS FOR PRODUCING POLYMER | Takeda Chemical Industries, Ltd. (JP) | 2001-11-28 | — | — | EP | disclosed |
| EP-1136079-A1 | AGENTS FOR RETARDING CHANGE OF HORMONE-DEPENDENT CANCER INTO HORMONE-INDEPENDENT CANCER | Takeda Chemical Industries, Ltd. (JP) | 2001-09-26 | — | — | EP | disclosed |
| EP-1048301-A1 | SUSTAINED RELEASE COMPOSITIONS, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-11-02 | — | — | EP | disclosed |